Global Regulatory DNA Potentiation by SMARCA4 Propagates to Selective Gene Expression Programs via Domain-Level Remodeling.

BAF complex SMARCA4 cancer epigenetics chromatin accessibility chromatin domains chromatin remodeling gene regulation lung adenocarcinoma topologically associating domains

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
26 05 2020
Historique:
received: 31 07 2019
revised: 23 12 2019
accepted: 30 04 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 22 5 2021
Statut: ppublish

Résumé

The human genome encodes millions of regulatory elements, of which only a small fraction are active within a given cell type. Little is known about the global impact of chromatin remodelers on regulatory DNA landscapes and how this translates to gene expression. We use precision genome engineering to reawaken homozygously inactivated SMARCA4, a central ATPase of the human SWI/SNF chromatin remodeling complex, in lung adenocarcinoma cells. Here, we combine DNase I hypersensitivity, histone modification, and transcriptional profiling to show that SMARCA4 dramatically increases both the number and magnitude of accessible chromatin sites genome-wide, chiefly by unmasking sites of low regulatory factor occupancy. By contrast, transcriptional changes are concentrated within well-demarcated remodeling domains wherein expression of specific genes is gated by both distal element activation and promoter chromatin configuration. Our results provide a perspective on how global chromatin remodeling activity is translated to gene expression via regulatory DNA.

Identifiants

pubmed: 32460018
pii: S2211-1247(20)30629-X
doi: 10.1016/j.celrep.2020.107676
pii:
doi:

Substances chimiques

Nuclear Proteins 0
Transcription Factors 0
DNA 9007-49-2
SMARCA4 protein, human EC 3.6.1.-
DNA Helicases EC 3.6.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107676

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG009444
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG007010
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests All authors are employees of the not-for-profit Altius Institute for Biomedical Sciences.

Auteurs

John E Lazar (JE)

Departments of Genome Sciences and Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA; Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Sandra Stehling-Sun (S)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Vivek Nandakumar (V)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Hao Wang (H)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Daniel R Chee (DR)

Departments of Genome Sciences and Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA; Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Nicholas P Howard (NP)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Reyes Acosta (R)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Douglass Dunn (D)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Morgan Diegel (M)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Fidencio Neri (F)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Andres Castillo (A)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Sean Ibarrientos (S)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Kristen Lee (K)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Ninnia Lescano (N)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Ben Van Biber (B)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Jemma Nelson (J)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Jessica Halow (J)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Richard Sandstrom (R)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Daniel Bates (D)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

Fyodor D Urnov (FD)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA.

John A Stamatoyannopoulos (JA)

Departments of Genome Sciences and Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA; Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA. Electronic address: jstam@uw.edu.

Alister P W Funnell (APW)

Altius Institute for Biomedical Sciences, Seattle, WA 98121, USA. Electronic address: afunnell@altius.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH